Open an account

Roundhill GLP-1 & Weight Loss ETF

OZEM · ETF

$29.64−$0.3414 (−1.14%)TodayMarket closed ·
Prev close $29.98

About OZEM

OZEM was created on 2024-05-21 by Roundhill. The fund's investment portfolio concentrates primarily on health care equity. The ETF currently has 54.97m in AUM and 26 holdings. OZEM is an actively managed fund that invests in companies from around the world involved in pharmaceutical drugs and supplements used for weight management.

Issuer
Roundhill
Expense ratio
0.59%
Assets under management
$56.12M
Inception
May 21, 2024
Asset class
Equity
Website
roundhillinvestments.com

OZEM key statistics

Price-earnings ratio
0.00
Average volume
12.13K
Volume
13.05K
Open price
$29.78
High today
$30.00
Low today
$29.50
52 Week high
$37.15
52 Week low
$27.41

Roundhill GLP-1 & Weight Loss ETF (OZEM) at a glance

Roundhill GLP-1 & Weight Loss ETF (OZEM) last traded at $29.64, with a price-to-earnings ratio of 0.00.

Today the fund has traded between $29.50 and $30.00. The current price is 0.5% above the day's low and 1.2% below its high.

Volume so far is 13.05K shares, in line with the average of 12.13K shares a day.

Over the past year Roundhill GLP-1 & Weight Loss ETF has ranged from $27.41 to $37.15, and now sits 23% of the way up that range.

OZEM news

  • Vandana Singh

    Food Companies Rethink Menus For GLP-1 Users As Wegovy Weight Loss Pill Gets Approval

  • Chandrima Sanyal

    Novo Nordisk's Stock Slump Shows The GLP‑1 Trade's Side Effect: ETF Concentration Risk

  • Press releasePRNewswire

    Roundhill Investments Surpasses $4 Billion AUM Milestone

  • Press releasePRNewswire

    Roundhill Investments Surpasses $2 Billion AUM Milestone

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.